Page last updated: 2024-08-21

dronabinol and Arterial Occlusive Diseases

dronabinol has been researched along with Arterial Occlusive Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bernatskaia, NA; Krylatov, AV; Maslov, LN; Mechoulam, R; Pertwee, RG; Sal'nikova, OM; SharaevskiÄ­, MA; Stefano, GB1
Abramsky, O; Leker, RR; Ovadia, H; Shohami, E1

Other Studies

2 other study(ies) available for dronabinol and Arterial Occlusive Diseases

ArticleYear
[Increase of the heart arrhythmogenic resistance and decrease of the myocardial necrosis zone during activation of cannabinoid receptors].
    Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova, 2002, Volume: 88, Issue:5

    Topics: Aconitine; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Arterial Occlusive Diseases; Camphanes; Cannabinoids; Coronary Artery Disease; Dronabinol; Epinephrine; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug; Rimonabant

2002
Dexanabinol; a novel neuroprotective drug in experimental focal cerebral ischemia.
    Journal of the neurological sciences, 1999, Jan-15, Volume: 162, Issue:2

    Topics: Animals; Arterial Occlusive Diseases; Disease Models, Animal; Dronabinol; Drug Evaluation, Preclinical; Excitatory Amino Acid Antagonists; Hypertension; Ischemic Attack, Transient; Male; Neuroprotective Agents; Nitric Oxide Synthase; Rats; Rats, Inbred SHR; Tumor Necrosis Factor-alpha

1999